NeuroSigma neurosigma.com


Public lists: Pharma Startups (4732)

NeuroSigma focuses on developing bioelectronic products to treat patients suffering from neurological and neuropsychiatric disorders. The company's lead product includes external trigeminal nerve stimulation (TNS) system (eTNS system), a non-invasive system for the treatment of drug-resistant epilepsy and depressive disorder. NeuroSigma is also designing and developing subcutaneous TNS systems for patients who have responded to eTNS system and prefer an implantable system.

NeuroSigma focuses on developing bioelectronic products to treat patients suffering from neurological and neuropsychiatric disorders. The company's lead product includes external trigeminal nerve stimulation (TNS) system (eTNS system), a non-invasive...Show all

Company (Alive / Active)

Phone: 310-479-3100

Fax:

10960 Wilshire Blvd.
Suite 1230
Los Angeles, 90024
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
NeuroSigma $12.2M Aug 31, 2016

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related NeuroSigma Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.